Short Interest in Carmell Co. (NASDAQ:CTCX) Declines By 5.5%

Carmell Co. (NASDAQ:CTCXGet Free Report) was the target of a large decline in short interest during the month of August. As of August 31st, there was short interest totalling 55,400 shares, a decline of 5.5% from the August 15th total of 58,600 shares. Approximately 0.4% of the company’s stock are short sold. Based on an average daily volume of 27,300 shares, the short-interest ratio is currently 2.0 days.

Carmell Trading Down 7.2 %

CTCX stock opened at $0.40 on Thursday. Carmell has a 52-week low of $0.40 and a 52-week high of $4.99. The business has a 50-day simple moving average of $0.91 and a two-hundred day simple moving average of $1.79.

Carmell (NASDAQ:CTCXGet Free Report) last issued its quarterly earnings data on Wednesday, August 14th. The company reported ($0.16) earnings per share (EPS) for the quarter. The business had revenue of $0.01 million for the quarter.

Institutional Trading of Carmell

A hedge fund recently bought a new stake in Carmell stock. Hubbell Strickland Wealth Management LLC purchased a new stake in shares of Carmell Co. (NASDAQ:CTCXFree Report) in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 12,548 shares of the company’s stock, valued at approximately $32,000. Hubbell Strickland Wealth Management LLC owned 0.07% of Carmell as of its most recent filing with the Securities & Exchange Commission. 24.22% of the stock is owned by institutional investors and hedge funds.

About Carmell

(Get Free Report)

Carmell Corporation operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Its Carmell Secretome consists of growth factors and proteins extracted from allogeneic human platelets sourced from tissue banks. The company also developed a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products.

Featured Stories

Receive News & Ratings for Carmell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carmell and related companies with MarketBeat.com's FREE daily email newsletter.